A Multiple-dose Study of LY3031207 in Healthy Participants
Stopped Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.
Conditions
Interventions
- DRUG: Placebo
- DRUG: LY3031207
- DRUG: Celecoxib
- DRUG: Simvastatin
Sponsor
Eli Lilly and Company